- Home
- AMTB vs LENZ Comparison
AMTB vs LENZ Comparison
Compare AMTB & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMTB
- LENZ
- Stock Information
- Founded
- AMTB 1979
- LENZ 2019
- Country
- AMTB United States
- LENZ United States
- Employees
- AMTB N/A
- LENZ N/A
- Industry
- AMTB Major Banks
- LENZ Medicinal Chemicals and Botanical Products
- Sector
- AMTB Finance
- LENZ Health Care
- Exchange
- AMTB Nasdaq
- LENZ Nasdaq
- Market Cap
- AMTB 837.4M
- LENZ 886.0M
- IPO Year
- AMTB N/A
- LENZ 2021
- Fundamental
- Price
- AMTB $20.09
- LENZ $33.19
- Analyst Decision
- AMTB Hold
- LENZ Strong Buy
- Analyst Count
- AMTB 5
- LENZ 5
- Target Price
- AMTB $24.33
- LENZ $41.80
- AVG Volume (30 Days)
- AMTB 218.4K
- LENZ 330.7K
- Earning Date
- AMTB 07-23-2025
- LENZ 05-07-2025
- Dividend Yield
- AMTB 1.80%
- LENZ N/A
- EPS Growth
- AMTB N/A
- LENZ N/A
- EPS
- AMTB N/A
- LENZ N/A
- Revenue
- AMTB $280,716,000.00
- LENZ N/A
- Revenue This Year
- AMTB $57.57
- LENZ N/A
- Revenue Next Year
- AMTB $8.91
- LENZ $544.90
- P/E Ratio
- AMTB N/A
- LENZ N/A
- Revenue Growth
- AMTB N/A
- LENZ N/A
- 52 Week Low
- AMTB $16.21
- LENZ $16.54
- 52 Week High
- AMTB $27.00
- LENZ $38.93
- Technical
- Relative Strength Index (RSI)
- AMTB 62.83
- LENZ 58.25
- Support Level
- AMTB $19.00
- LENZ $33.51
- Resistance Level
- AMTB $20.11
- LENZ $35.87
- Average True Range (ATR)
- AMTB 0.56
- LENZ 1.99
- MACD
- AMTB 0.02
- LENZ 0.02
- Stochastic Oscillator
- AMTB 54.41
- LENZ 68.34
About AMTB Amerant Bancorp Inc.
Amerant Bancorp Inc is a bank holding company. Through its bank, it provides individuals and businesses deposit, credit, investment, wealth management, and fiduciary services, both in the United States and to select international customers. The bank also provides banking services through traditional channels, such as banking centers and ATMs, as well as via secure websites, mobile devices and telephones.
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.